Localized surface plasmon resonance-based point-of-care testing for pediatric sepsis

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Clinical Diagnostics

Background:

• Sepsis is a major global cause of child mortality.
• Current diagnostic methods for pediatric sepsis are often too slow for effective, timely intervention.
• There is a critical need for rapid, accurate diagnostic tools for pediatric sepsis.

Purpose of the Study:

• To review the role of localized surface plasmon resonance (LSPR) technology in developing point-of-care testing (POCT) platforms for pediatric sepsis.
• To analyze the principles, design, and performance of LSPR-based POCT systems for sepsis diagnosis.
• To evaluate the potential clinical impact and future directions of LSPR-POCT in various healthcare settings.

Main Methods:

• Review of existing literature on LSPR technology and its application in sepsis diagnostics.
• Explanation of the physical principles of LSPR for label-free biomolecular detection.
• Critical analysis of LSPR-based POCT systems, including design, biomarkers, and performance metrics from validation studies.

Main Results:

• LSPR enables sensitive, label-free detection of biomolecular interactions crucial for sepsis diagnosis.
• LSPR-based POCT platforms demonstrate potential for rapid and accurate detection of sepsis biomarkers.
• Studies show promising performance metrics for LSPR-POCT in sepsis detection.

Conclusions:

• LSPR-POCT represents a significant advancement in addressing the diagnostic challenges of pediatric sepsis.
• This technology offers the necessary speed and sensitivity for timely clinical management.
• LSPR-POCT has the potential to revolutionize pediatric sepsis diagnosis in both high-resource and limited-resource settings.